The ANA, or antinuclear antibody test, is a blood test that detects antibodies attacking the nucleus of your own cells. It’s one of the most commonly ordered tests when a doctor suspects an autoimmune condition, particularly lupus. A positive result doesn’t mean you have an autoimmune disease, though. Roughly 25% of healthy people test positive, and the result only becomes meaningful when combined with your symptoms and follow-up testing.
What Antinuclear Antibodies Are
Your immune system normally produces antibodies to fight infections. Antinuclear antibodies are different: they mistakenly target proteins inside the nuclei of your own cells. “Antinuclear” literally means “against the nucleus.” When these antibodies show up in high enough concentrations, they can signal that the immune system is attacking the body’s own tissues, which is the hallmark of autoimmune disease.
The ANA test doesn’t diagnose a specific condition on its own. It functions more like a screening tool, flagging that something autoimmune might be going on. The 2019 classification criteria from the two major rheumatology organizations in Europe and the U.S. made a positive ANA a mandatory entry requirement for classifying someone as having lupus. That reflects how central this test is to the diagnostic process, but also how it’s just the first step.
How the Test Works
A technician draws a small vial of blood, usually from a vein in your arm. No fasting is required for the ANA test itself, though if your doctor ordered additional blood work at the same time, you may need to skip food or drink beforehand. Bring a list of your current medications, since some can influence results.
The traditional method uses a technique called indirect immunofluorescence. Your blood serum is placed on a slide containing human cells, and if antinuclear antibodies are present, they bind to the cell nuclei. A fluorescent dye is then applied so a lab technician can see the pattern and intensity under a microscope. This method is highly sensitive but also labor-intensive and depends partly on the technician’s experience in reading the slides.
Many labs now use an automated method that screens for antibodies against a panel of specific proteins, sometimes including 17 different targets. This approach is faster and more standardized, and it can catch certain antibodies that the microscope method misses, particularly antibodies that target structures outside the nucleus. Both methods are widely accepted, though your doctor may prefer one over the other depending on your clinical picture.
Understanding Your Results
ANA results from the microscope method are reported as a titer, which is a ratio showing how many times your blood sample could be diluted and still test positive. A result of 1:40 or lower is considered negative. A result of 1:160 or higher is considered significantly positive. Values in between fall into a gray zone that your doctor will interpret alongside your symptoms.
The higher the titer, the more likely the result is clinically meaningful. But even high titers don’t guarantee disease. The key context: up to 25% of the healthy population tests positive for ANA using standard methods, and in some studies that figure reaches 40% at low titers. Among healthy people tested using older techniques, about 1% reach a titer of 1:160. So a low positive result in someone without symptoms is very common and usually not a cause for concern.
If the automated method was used instead, results are reported as a numerical ratio. A value of 1.0 or higher is positive, 0.7 to 0.99 is equivocal, and below 0.7 is negative.
What the Patterns Mean
When the microscope method is used, the lab also reports the staining pattern, which describes how the fluorescent glow appears on the cell. Different patterns correspond to different types of antibodies, and those antibodies point toward different diseases.
- Homogeneous: The entire nucleus glows uniformly. This pattern results from antibodies targeting DNA and proteins called histones. It’s most associated with lupus.
- Speckled: The nucleus shows scattered bright dots. This comes from antibodies against specific extractable proteins and is seen across several autoimmune conditions, including lupus and mixed connective tissue disease.
- Nucleolar: Only the small dense structures within the nucleus light up. This pattern is linked to antibodies like those targeting an enzyme called topoisomerase-1, and it raises suspicion for systemic sclerosis (scleroderma).
- Centromere: Discrete dots appear in a characteristic arrangement. This pattern is also associated with systemic sclerosis, particularly the limited form of the disease.
The pattern gives your doctor a direction for further testing, but it’s not diagnostic by itself.
Conditions Linked to a Positive ANA
The ANA test is most strongly associated with systemic lupus erythematosus. The test has a sensitivity of about 98% for lupus at a titer of 1:80, meaning it catches nearly all cases. A persistently negative ANA essentially rules lupus out under current classification criteria.
Antinuclear antibodies are also detected in more than 90% of people with systemic sclerosis. Other conditions that commonly produce a positive ANA include Sjögren’s syndrome, mixed connective tissue disease, polymyositis, dermatomyositis, and autoimmune hepatitis. Rheumatoid arthritis and thyroid autoimmune conditions can produce positive results too, though less consistently.
Why You Can Test Positive Without Disease
A positive ANA in someone without autoimmune disease is extremely common, and several factors can explain it. Age is one: the prevalence of low-level antinuclear antibodies increases as you get older, even in perfectly healthy people. Infections, including viral illnesses, can temporarily trigger a positive result. Certain cancers can also cause the immune system to produce these antibodies.
Medications are another well-known cause. Drugs that have a strong track record of inducing a positive ANA or even a lupus-like syndrome include hydralazine (a blood pressure medication), procainamide (a heart rhythm drug), isoniazid (a tuberculosis treatment), and minocycline (an antibiotic often used for acne). Several newer biologic therapies, particularly TNF inhibitors used for conditions like rheumatoid arthritis and Crohn’s disease, and immune checkpoint inhibitors used in cancer treatment, have also been linked to lupus-like reactions. Even some herbal products, including echinacea and alfalfa sprouts, have been associated with flares in people who are susceptible.
When a medication is the cause, symptoms and antibodies typically resolve after stopping the drug.
What Happens After a Positive Result
A positive ANA almost always triggers follow-up testing. The most common next step is an ENA panel, which stands for extractable nuclear antigen panel. This test looks for antibodies against four to six specific proteins, and the results help narrow down which autoimmune condition, if any, is present.
The antibodies typically included in an ENA panel are:
- Anti-SSA (also called Anti-Ro): Associated with Sjögren’s syndrome and lupus.
- Anti-SSB (also called Anti-La): Also linked to Sjögren’s syndrome.
- Anti-Smith: Highly specific for lupus.
- Anti-RNP: Seen in mixed connective tissue disease and lupus.
- Anti-Scl-70: Points toward systemic sclerosis.
- Anti-Jo-1: Associated with inflammatory muscle diseases like polymyositis.
Your doctor may also order an anti-double-stranded DNA test, which is another antibody highly specific for lupus, along with blood counts, kidney function tests, and inflammatory markers. The goal is to match your antibody profile with your symptoms and physical exam findings. A positive ANA with no specific antibodies on follow-up testing and no symptoms is typically monitored over time rather than treated.